https://orcid.org/0000-0003-1197-2641
References
- Bell M, Eriksson LI, Svensson T, et al. Days at home after surgery: an integrated and efficient outcome measure for clinical trials and quality assurance. EClinicalMedicine. 2019;11:18–26.
- Ariti CA, Cleland JGF, Pocock SJ, et al. Days alive and out of hospital and the patient journey in patients with heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J. 2011;162(5):900–906.
- Fanaroff AC, Cyr D, Neely ML, et al. Days alive and out of hospital: exploring a patient-centered, pragmatic outcome in a clinical trial of patients with acute coronary syndromes. Circ Cardiovasc Qual Outcomes. 2018;11:e004755.
- Myles PS, Shulman MA, Heritier S, et al. Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia. BMJ Open. 2017;7(8):e015828.
- Jørgensen CC, Petersen PB, Kehlet H, et al. Days alive and out of hospital after fast-track total hip and knee arthroplasty: an observational cohort study in 16,137 patients. Br J Anaesth. 2019;123(5):671–678.
- Brennan JM, Thomas L, Cohen DJ, et al. Transcatheter versus surgical aortic valve replacement: propensity-matched comparison. J Am Coll Cardiol. 2017;70(4):439–450.
- Jerath A, Austin PC, Ko DT, et al. Socioeconomic status and days alive and out of hospital after major elective noncardiac surgery: a population-based cohort study. Anesthesiology. 2020;132(4):713–722.
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
- Zamani M, Grønhøj C, Jensen DH, et al. The current epidemic of HPV-associated oropharyngeal cancer: an 18-year Danish population-based study with 2,169 patients. Eur J Cancer. 2020;134:52–59.
- Dowthwaite SA, Franklin JH, Palma DA, et al. The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature. ISRN Oncol. 2012;2012:945114–945162.
- Chen MM, Roman SA, Kraus DH, et al. Transoral robotic surgery: a population-level analysis. Otolaryngol Head Neck Surg. 2014;150(6):968–975.
- Scott SI, Madsen AKØ, Rubek N, et al. Time course of subacute pain after transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma versus traditional bilateral tonsillectomy in adults – a case-control study. Acta Otolaryngol. 2018;138(9):837–842.
- Chung TK, Rosenthal EL, Magnuson JS, et al. Transoral robotic surgery for oropharyngeal and tongue cancer in the United States. Laryngoscope. 2015;125(1):140–145.
- Aubry K, Vergez S, de Mones E, et al. Morbidity and mortality revue of the French group of transoral robotic surgery: a multicentric study. J Robot Surg. 2016;10(1):63–67.
- Richmon JD, Feng AL, Yang W, et al. Feasibility of rapid discharge after transoral robotic surgery of the oropharynx. Laryngoscope. 2014;124(11):2518–2525.
- Isenberg A, Lou Channir HI, Buchwald VC, et al. Transoral robotic surgery: a 4-year learning experience in a single Danish Cancer Centre. Acta Otolaryngol. 2019;0:1–6.
- DAHANCA. DAHANCA National guidelines regarding carcinoma of unknown primary. Available from: https://www.dahanca.oncology.dk/assets/files/GUID_Ukendt%20primaertumor.pdf. 2013.
- Clayburgh D, Stott W, Bolognone R, et al. A randomized controlled trial of corticosteroids for pain after transoral robotic surgery. Laryngoscope. 2017;127(11):2558–2564.
- Hinami K, Bilimoria KY, Kallas PG, et al. Patient experiences after hospitalizations for elective surgery. Am J Surg. 2014;207(6):855–862.
- Buggy DJ, Freeman J, Johnson MZ, et al. Systematic review and consensus definitions for standardised endpoints in perioperative medicine: postoperative cancer outcomes. Br J Anaesth. 2018;121(1):38–44.